Ambea AB (publ) AMBEA.ST
Nasdaq Stockholm · Healthcare · Medical Care Facilities
191.80 SEK
+3.9%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Ambea
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 12,635 | 13,312 | 14,195 | 16,039 |
| EBITDA | 2,003 | 2,251 | 2,618 | 2,846 |
| Net income | 366 | 455 | 620 | 665 |
| Balance sheet | ||||
| Equity | 4,681 | 4,920 | 4,986 | 5,200 |
| Total debt | 10,959 | 10,745 | 10,757 | 12,643 |
| Cash | 259 | 6 | 28 | 133 |
| Net debt | 10,700 | 10,739 | 10,729 | 12,510 |
| Ratios and per share | ||||
| EBITDA margin | 15.9% | 16.9% | 18.4% | 17.7% |
| Profit margin | 2.9% | 3.4% | 4.4% | 4.1% |
| Return on equity | 7.8% | 9.2% | 12.4% | 12.8% |
| Earnings/share (SEK) | 4.04 | 5.08 | 7.39 | 8.10 |
| Book value/share (SEK) | 51.62 | 54.93 | 59.46 | 63.34 |
| Shares outstanding (M) | 91 | 90 | 84 | 82 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 23.7 |
| P/B | 3.0 |
| EV / EBITDA | 9.9 |
| Net debt / EBITDA | 4.4 |
| Return on equity | 12.8% |
| Profit margin | 4.2% |
| Beta 1Y | 0.39 |
| Revenue growth 1Y | +13.0% |
| Revenue CAGR 3Y | +8.3% |
| Earnings/share CAGR 3Y | +26.1% |
| ROE avg. 3Y | 11.5% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 2.65 |
| 2025 | 2.20 |
| 2024 | 1.50 |
| 2023 | 1.25 |
| 2022 | 1.15 |
Not investment advice. Figures may contain errors from the data source.